Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/15796206
Conclusion of this study
One 10-year-old male patient, with a known pineapple allergy, showed a self-limiting mild allergic reaction. No other unwanted side-effects were reported. This trial documents that the proteolytic pineapple enzyme Bromelain-POS is widely used in the treatment of young children diagnosed with acute sinusitis in Germany and that the use of proteolytic enzymes can benefit such patients.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study